Conning Inc. Has $398,000 Holdings in Synopsys, Inc. $SNPS

Conning Inc. lessened its stake in Synopsys, Inc. (NASDAQ:SNPS) by 4.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 776 shares of the semiconductor company’s stock after selling 40 shares during the quarter. Conning Inc.’s holdings in Synopsys were worth $398,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in Synopsys by 2.4% in the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock valued at $6,359,747,000 after acquiring an additional 346,994 shares during the last quarter. Pictet Asset Management Holding SA lifted its stake in Synopsys by 38.3% in the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock valued at $1,043,518,000 after purchasing an additional 673,837 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in Synopsys by 6.6% in the 1st quarter. Ameriprise Financial Inc. now owns 2,013,380 shares of the semiconductor company’s stock valued at $863,500,000 after purchasing an additional 125,199 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Synopsys by 20.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock valued at $778,928,000 after buying an additional 305,489 shares during the last quarter. Finally, Alliancebernstein L.P. lifted its position in shares of Synopsys by 22.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock valued at $739,857,000 after buying an additional 313,218 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Trading Down 9.4%

Shares of NASDAQ:SNPS opened at $438.92 on Friday. The business’s 50 day simple moving average is $544.01 and its 200 day simple moving average is $510.54. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. The company has a market capitalization of $81.53 billion, a P/E ratio of 34.45, a P/E/G ratio of 4.84 and a beta of 1.10.

Synopsys (NASDAQ:SNPS) last released its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.75 by ($1.45). The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.77 billion. Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The business’s revenue for the quarter was up 14.0% compared to the same quarter last year. During the same period last year, the company posted $3.43 earnings per share. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Insider Activity

In other news, CFO Shelagh Glaser sold 3,655 shares of the business’s stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the completion of the transaction, the chief financial officer directly owned 15,317 shares in the company, valued at approximately $9,339,847.09. The trade was a 19.27% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert G. Painter bought 350 shares of the company’s stock in a transaction dated Thursday, September 11th. The stock was purchased at an average price of $425.44 per share, with a total value of $148,904.00. Following the completion of the transaction, the director directly owned 2,291 shares in the company, valued at approximately $974,683.04. This represents a 18.03% increase in their position. The disclosure for this purchase can be found here. Insiders have sold a total of 30,894 shares of company stock valued at $16,760,783 over the last quarter. 0.62% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. JPMorgan Chase & Co. cut their price target on Synopsys from $685.00 to $600.00 and set an “overweight” rating for the company in a report on Wednesday, September 10th. The Goldman Sachs Group cut their price objective on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating for the company in a research report on Wednesday, September 10th. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research report on Wednesday. Rosenblatt Securities restated a “neutral” rating and set a $605.00 price objective (down from $650.00) on shares of Synopsys in a research report on Wednesday, September 10th. Finally, Bank of America reissued an “underperform” rating and set a $525.00 price target (down from $625.00) on shares of Synopsys in a report on Wednesday, September 10th. Eleven equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, Synopsys has a consensus rating of “Hold” and an average price target of $575.31.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.